General Information of Drug Transporter (DT)
DT ID DTD0418 Transporter Info
Gene Name SLC5A1
Transporter Name Sodium/glucose cotransporter 1
Gene ID
6523
UniProt ID
P13866
Epigenetic Regulations of This DT (EGR)

Methylation

  Breast cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A1 in breast cancer [ 1 ]

Location

TSS1500 (cg13818276)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.19E+00 Statistic Test p-value: 1.12E-08; Z-score: 1.33E+00

Methylation in Case

5.13E-01 (Median) Methylation in Control 4.31E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A1 in breast cancer [ 1 ]

Location

TSS1500 (cg09327378)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 4.32E-02; Z-score: 7.79E-01

Methylation in Case

8.04E-01 (Median) Methylation in Control 7.76E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A1 in breast cancer [ 1 ]

Location

Body (cg14395060)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.22E+00 Statistic Test p-value: 1.98E-04; Z-score: -8.37E-01

Methylation in Case

2.69E-01 (Median) Methylation in Control 3.29E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A1 in breast cancer [ 1 ]

Location

3'UTR (cg20495476)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.09E+00 Statistic Test p-value: 5.52E-04; Z-score: -9.23E-01

Methylation in Case

6.06E-01 (Median) Methylation in Control 6.59E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

           8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A1 in hepatocellular carcinoma [ 2 ]

Location

TSS1500 (cg13818276)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.21E+00 Statistic Test p-value: 1.90E-08; Z-score: -1.75E+00

Methylation in Case

4.77E-01 (Median) Methylation in Control 5.80E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A1 in hepatocellular carcinoma [ 2 ]

Location

TSS1500 (cg09327378)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.10E+00 Statistic Test p-value: 2.62E-07; Z-score: -1.03E+00

Methylation in Case

7.41E-01 (Median) Methylation in Control 8.13E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A1 in hepatocellular carcinoma [ 2 ]

Location

TSS200 (cg19277154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.12E+00 Statistic Test p-value: 3.09E-03; Z-score: -5.70E-01

Methylation in Case

3.29E-01 (Median) Methylation in Control 3.67E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A1 in hepatocellular carcinoma [ 2 ]

Location

TSS200 (cg26730347)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.24E+00 Statistic Test p-value: 4.98E-03; Z-score: 1.14E+00

Methylation in Case

4.31E-01 (Median) Methylation in Control 3.47E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A1 in hepatocellular carcinoma [ 2 ]

Location

Body (cg16548605)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.54E+00 Statistic Test p-value: 4.37E-11; Z-score: -1.94E+00

Methylation in Case

3.99E-01 (Median) Methylation in Control 6.15E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC5A1 in hepatocellular carcinoma [ 2 ]

Location

Body (cg24946795)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.31E+00 Statistic Test p-value: 2.43E-10; Z-score: 1.50E+00

Methylation in Case

5.71E-01 (Median) Methylation in Control 4.37E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC5A1 in hepatocellular carcinoma [ 2 ]

Location

Body (cg09672032)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 1.39E-05; Z-score: -8.61E-01

Methylation in Case

7.48E-01 (Median) Methylation in Control 8.01E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC5A1 in hepatocellular carcinoma [ 2 ]

Location

Body (cg14395060)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 1.46E-02; Z-score: -3.39E-01

Methylation in Case

5.59E-01 (Median) Methylation in Control 5.82E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  HIV infection

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A1 in HIV infection [ 3 ]

Location

TSS1500 (cg13818276)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.12E+00 Statistic Test p-value: 1.45E-04; Z-score: -1.44E+00

Methylation in Case

6.11E-01 (Median) Methylation in Control 6.88E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A1 in HIV infection [ 3 ]

Location

TSS1500 (cg09327378)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 6.26E-04; Z-score: -9.26E-01

Methylation in Case

8.79E-01 (Median) Methylation in Control 8.99E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A1 in HIV infection [ 3 ]

Location

1stExon (cg00500507)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.07E+00 Statistic Test p-value: 1.67E-02; Z-score: 4.47E-01

Methylation in Case

5.53E-01 (Median) Methylation in Control 5.17E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A1 in HIV infection [ 3 ]

Location

Body (cg09672032)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 1.03E-02; Z-score: -7.54E-01

Methylation in Case

8.97E-01 (Median) Methylation in Control 9.19E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A1 in HIV infection [ 3 ]

Location

3'UTR (cg20495476)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 7.21E-04; Z-score: -1.11E+00

Methylation in Case

7.25E-01 (Median) Methylation in Control 7.73E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A1 in lung adenocarcinoma [ 4 ]

Location

TSS1500 (cg09327378)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 4.08E-02; Z-score: -1.75E+00

Methylation in Case

8.25E-01 (Median) Methylation in Control 8.60E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A1 in lung adenocarcinoma [ 4 ]

Location

Body (cg09672032)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 3.35E-02; Z-score: -1.51E+00

Methylation in Case

8.21E-01 (Median) Methylation in Control 8.69E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A1 in pancretic ductal adenocarcinoma [ 5 ]

Location

TSS1500 (cg09110274)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.22E+00 Statistic Test p-value: 1.87E-05; Z-score: -1.19E+00

Methylation in Case

6.22E-01 (Median) Methylation in Control 7.62E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A1 in pancretic ductal adenocarcinoma [ 5 ]

Location

Body (cg01971363)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.02E+00 Statistic Test p-value: 3.03E-06; Z-score: 9.90E-01

Methylation in Case

8.91E-01 (Median) Methylation in Control 8.77E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A1 in pancretic ductal adenocarcinoma [ 5 ]

Location

3'UTR (cg04092332)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.01E+00 Statistic Test p-value: 2.01E-02; Z-score: 3.56E-01

Methylation in Case

8.93E-01 (Median) Methylation in Control 8.87E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A1 in papillary thyroid cancer [ 6 ]

Location

TSS1500 (cg13818276)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 7.36E-05; Z-score: -5.27E-01

Methylation in Case

6.82E-01 (Median) Methylation in Control 7.11E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A1 in papillary thyroid cancer [ 6 ]

Location

TSS1500 (cg09327378)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 3.43E-04; Z-score: -9.42E-01

Methylation in Case

9.11E-01 (Median) Methylation in Control 9.29E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A1 in papillary thyroid cancer [ 6 ]

Location

Body (cg14395060)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 2.61E-04; Z-score: -8.14E-01

Methylation in Case

6.78E-01 (Median) Methylation in Control 7.22E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A1 in papillary thyroid cancer [ 6 ]

Location

Body (cg09672032)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 3.63E-04; Z-score: -7.13E-01

Methylation in Case

8.72E-01 (Median) Methylation in Control 8.94E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A1 in papillary thyroid cancer [ 6 ]

Location

3'UTR (cg20495476)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 2.63E-04; Z-score: -5.38E-01

Methylation in Case

7.59E-01 (Median) Methylation in Control 7.88E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Bladder cancer

           5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A1 in bladder cancer [ 7 ]

Location

TSS200 (cg26730347)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -3.35E+00 Statistic Test p-value: 4.52E-05; Z-score: -5.00E+00

Methylation in Case

1.26E-01 (Median) Methylation in Control 4.22E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A1 in bladder cancer [ 7 ]

Location

TSS200 (cg19277154)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.85E+00 Statistic Test p-value: 6.62E-05; Z-score: -3.56E+00

Methylation in Case

2.06E-01 (Median) Methylation in Control 3.81E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A1 in bladder cancer [ 7 ]

Location

Body (cg09672032)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.26E-02; Z-score: -5.82E-01

Methylation in Case

8.27E-01 (Median) Methylation in Control 8.42E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A1 in bladder cancer [ 7 ]

Location

Body (cg14395060)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.63E+00 Statistic Test p-value: 1.60E-02; Z-score: -1.73E+00

Methylation in Case

1.39E-01 (Median) Methylation in Control 2.26E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC5A1 in bladder cancer [ 7 ]

Location

3'UTR (cg20495476)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.52E+00 Statistic Test p-value: 1.98E-07; Z-score: -1.23E+01

Methylation in Case

4.89E-01 (Median) Methylation in Control 7.44E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Atypical teratoid rhabdoid tumor

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A1 in atypical teratoid rhabdoid tumor [ 8 ]

Location

1stExon (cg00500507)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.64E+00 Statistic Test p-value: 2.93E-29; Z-score: -4.92E+00

Methylation in Case

4.82E-01 (Median) Methylation in Control 7.88E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC5A1 in atypical teratoid rhabdoid tumor [ 8 ]

Location

Body (cg09672032)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 1.17E-02; Z-score: -3.65E-01

Methylation in Case

6.90E-01 (Median) Methylation in Control 7.18E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC5A1 in atypical teratoid rhabdoid tumor [ 8 ]

Location

Body (cg14395060)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.79E+00 Statistic Test p-value: 4.61E-02; Z-score: -2.30E-01

Methylation in Case

2.46E-02 (Median) Methylation in Control 4.40E-02 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC5A1 in atypical teratoid rhabdoid tumor [ 8 ]

Location

3'UTR (cg20495476)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 4.15E-10; Z-score: -1.85E+00

Methylation in Case

8.15E-01 (Median) Methylation in Control 9.04E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Colon cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A1 in colon adenocarcinoma [ 9 ]

Location

1stExon (cg13223402)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 6.45E+00 Statistic Test p-value: 7.80E-07; Z-score: 1.60E+01

Methylation in Case

3.74E-01 (Median) Methylation in Control 5.80E-02 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Renal cell carcinoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A1 in clear cell renal cell carcinoma [ 10 ]

Location

Body (cg14395060)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.25E+00 Statistic Test p-value: 3.06E-07; Z-score: -2.09E+00

Methylation in Case

5.98E-01 (Median) Methylation in Control 7.46E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Prostate cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A1 in prostate cancer [ 11 ]

Location

Body (cg10718608)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.17E+00 Statistic Test p-value: 4.05E-02; Z-score: 1.73E+00

Methylation in Case

8.30E-01 (Median) Methylation in Control 7.11E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Panic disorder

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC5A1 in panic disorder [ 12 ]

Location

3'UTR (cg20495476)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.07E+00 Statistic Test p-value: 1.86E-03; Z-score: 2.99E-01

Methylation in Case

2.11E+00 (Median) Methylation in Control 1.97E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Atypical teratoid rhabdoid tumour

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypermethylation of SLC5A1 in atypical teratoid rhabdoid tumour than that in healthy individual

Studied Phenotype

Atypical teratoid rhabdoid tumour [ICD-11:2A00.1Y]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 8.41E-10; Fold-change: 0.253869675; Z-score: 1.106239955
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Melanocytoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypermethylation of SLC5A1 in melanocytoma than that in healthy individual

Studied Phenotype

Melanocytoma [ICD-11:2F36.2]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.00014002; Fold-change: 0.242658395; Z-score: 1.138539205
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Brain neuroblastoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC5A1 in brain neuroblastoma than that in healthy individual

Studied Phenotype

Brain neuroblastoma [ICD-11:2A00.11]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.05E-06; Fold-change: -0.289427176; Z-score: -1.458106882
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Multilayered rosettes embryonal tumour

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC5A1 in multilayered rosettes embryonal tumour than that in healthy individual

Studied Phenotype

Multilayered rosettes embryonal tumour [ICD-11:2A00.1]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 1.64E-08; Fold-change: -0.285514572; Z-score: -1.600053438
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Ovarian cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC5A1 in ovarian cancer than that in healthy individual

Studied Phenotype

Ovarian cancer [ICD-11:2C73]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.026578706; Fold-change: -0.276051372; Z-score: -1.319748764
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Uterine carcinosarcoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate hypomethylation of SLC5A1 in uterine carcinosarcoma than that in healthy individual

Studied Phenotype

Uterine carcinosarcoma [ICD-11:2B5F]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.047361815; Fold-change: -0.277537973; Z-score: -1.326855921
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Craniopharyngioma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC5A1 in craniopharyngioma than that in healthy individual

Studied Phenotype

Craniopharyngioma [ICD-11:2F9A]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.001954551; Fold-change: -0.316564274; Z-score: -1.317888553
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Lung cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypomethylation of SLC5A1 in lung cancer than that in adjacent tissue

Studied Phenotype

Lung cancer [ICD-11:2C25]

The Methylation Level of Disease Section Compare with the Adjacent Tissue

p-value: 2.69E-06; Fold-change: -0.314685186; Z-score: -3.933670666
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
DT methylation level in tissue other than the diseased tissue of patients

microRNA

  Unclear Phenotype

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

miR-335 directly targets SLC5A1 [ 13 ]

Epigenetic Type

microRNA Experiment Method Microarray

miRNA Stemloop ID

miR-335 miRNA Mature ID miR-335-5p

miRNA Sequence

UCAAGAGCAAUAACGAAAAAUGU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human
References
1 Genome-wide Scan for Methylation Profiles in Breast Cancer
2 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
3 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
4 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
5 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
6 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
7 DNA Methylation Dynamics in Urological Tumors.
8 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
9 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
10 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
11 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
12 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
13 Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008 Jan 10;451(7175):147-52.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.